The experiments were not designed to establish that ovulation caused women to buy luxury goods, that the purchases attracted attention, or that they improved women’s prospects of attracting a mate. Led by Aekyoung Kim of Jeonbuk National University in the Republic of Korea and colleagues, the study examined whether preferences for conspicuous luxury changed during the fertile phase of the menstrual cycle. The researchers used urine samples to measure hormone levels and a survey method to estimate each woman’s current cycle phase.

Their prediction was that women near ovulation would favor visible luxury signals, such as prominently displayed brand logos, because such signals could help them be noticed by men. In the first experiment, 70 female university students drew the logos of luxury brands including Gucci, Chanel and Louis Vuitton. The students drew larger logos near ovulation than during the low-fertility phase of the cycle.

This result supports an association between ovulatory status and a preference for more conspicuous branding, although this experiment alone did not directly test the proposed mate-attraction mechanism. In the second experiment, 1,486 women reported their purchase intentions for luxury and nonluxury brands. Women near ovulation showed increased interest in luxury products intended for consumption in public, but not in luxury products intended for private use.

The difference is consistent with the idea that the association depends on the visibility of a luxury signal, though stated purchase intentions do not demonstrate that women subsequently made the purchases. The third experiment included 966 participants and tested whether beliefs about attention from men could moderate luxury choices. Women near ovulation were more likely to choose a $100 gift certificate from a luxury brand, such as Polo Ralph Lauren, than one from a nonluxury brand, such as Old Navy.

After reading research findings indicating that men do not notice women’s designer clothes, however, participants were less likely to choose a luxury brand, including those near ovulation. This result directly addressed the proposed mechanism: the preference weakened when participants believed that men did not pay attention to the signal. It does not show that conspicuous luxury actually increases attention, creates romantic opportunities or provides a reproductive advantage.

Taken together, the three experiments provide experimental evidence that ovulatory status is associated with stronger preferences for visible luxury symbols, with the third experiment also showing that beliefs about whether men notice such signals influence those choices. The findings remain limited to the populations and tasks studied, and the authors cautioned that they do not apply to every context in which women attempt to attract men. The studies did not measure whether the intended purchases occurred or whether real-world social and romantic outcomes changed.

Subject of Research: Experimental study of ovulatory status and women’s conspicuous luxury preferences

Article Title: Fertility may drive women’s desire for luxury

Article References: Fertility may drive women’s desire for luxury. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: ovulation, fertility, conspicuous consumption, luxury brands, menstrual cycle, consumer behavior, mate attention, hormonal contraception, PLOS One, drive, women, desire

Researchers collected 47 G. firmus and 39 G. pennsylvanicus females from allopatric Connecticut and Vermont populations in September 2020. They kept the field-mated females in individual cages with food, water and oviposition dishes for two additional months. All eggs from each female were incubated together, and surviving offspring were counted after a period at 6°C followed by incubation at 25°C.

Among 44 scored G. firmus broods, 11 females had male-like profiles and produced an average of 74.2 offspring, compared with 95.3 among 33 females with non-male-like profiles. In G. pennsylvanicus, 11 male-like females averaged 132 offspring, while 27 females with non-male-like profiles averaged 183. Statistical models associated the male-like category with fewer offspring in both species, with p-values below 0.001.

The analysis did not find strong evidence that hydrocarbon category was associated with whether a female produced any offspring (p = 0.09). Across categories, G. firmus females averaged 90 offspring per brood and G. pennsylvanicus averaged 168, a significant difference in the fitted models. This species contrast differed from earlier laboratory observations, but it does not establish a temporal change in fertility.

A separate analysis genotyped 29 G. firmus and 19 G. pennsylvanicus broods using seven microsatellite loci and inferred parentage from multilocus genotypes. It estimated a minimum number of contributing sires because males that fertilized no offspring, or only a single offspring, could not necessarily be detected.

For G. firmus, the estimated minimum sire count averaged 6 for male-like females and 5.5 for typical females. For G. pennsylvanicus, the corresponding means were 8.8 and 8. Neither within-species difference was statistically significant, with p = 0.6 in both cases. Broods from G. pennsylvanicus had a higher estimated minimum sire count than those from G. firmus, with means of 8.2 and 5.6, respectively.

The inferred paternity distribution departed strongly from a fair-raffle pattern in which each male would be expected to contribute similar numbers of offspring. Approximately 81% of individual broods rejected that expectation at the 0.05 significance level, and the combined test gave p approximately zero. The observed pattern was consistent with a loaded raffle, in which one or a few males accounted for a disproportionate share of paternity.

Because field mating was not experimentally controlled, the study could not determine why sperm use was unequal. The authors considered possible differences in sperm quantity or quality, repeated mating with the same males, and nonrandom mixing within the spermatheca, but did not establish which mechanism produced the pattern.

The results do not support male-like cuticular hydrocarbon profiles as indicators of greater fertility in the laboratory conditions tested or as signals of more contributing sires. The study did not measure field fertility, survival, access to food or offspring fitness, and its laboratory setting provided abundant food. The findings therefore do not exclude other fitness advantages or explain the mechanism behind the unequal paternity distribution.

Subject of Research: An animal study of cuticular hydrocarbon profiles, measured offspring production, and inferred paternity in two field cricket species

Article Title: Do favored cuticular hydrocarbon profiles signal fertility? Analysis of Gryllus firmus and Gryllus pennsylvanicus

Article References: Lee, E. H., Kim, J. Y., Lee, J., Cook, N., Heggeseth, B., & Maroja, L. S. (2026). Do favored cuticular hydrocarbon profiles signal fertility? Analysis of Gryllus firmus and Gryllus pennsylvanicus. Journal of Orthoptera Research, 35(1), 69-76. https://doi.org/10.3897/jor.35.161638

Image Credits: AI Generated

DOI: 10.3897/jor.35.161638

Keywords: Gryllus firmus, Gryllus pennsylvanicus, cuticular hydrocarbons, fertility, paternity analysis, sperm competition, field crickets, animal study, microsatellite genotyping, favored, cuticular, hydrocarbon

The study pooled data from six Malawi Demographic and Health Surveys conducted between 1992 and 2024. Using survey-weighted Poisson regression, the team examined whether women who had experienced one or more under-five deaths had higher parity, meaning the total number of children they had ever borne, than women whose children had all survived. They also tested whether the association varied by age and historical period, and separately examined complete birth histories to determine whether women who lost a child subsequently went on to have another baby.

Each additional under-five death was associated with a 13.9% higher incidence rate of parity, with an incidence rate ratio of 1.139 and a p-value below 0.001. The relationship was much stronger when women were grouped by whether they had experienced child loss at all. Compared with women reporting no loss, those with one death had an incidence rate ratio of 1.788 for parity, while those with two or more losses had a ratio of 2.637. In practical terms, the models indicate that cumulative bereavement is linked not merely to a small statistical shift, but to markedly different reproductive histories.

Age-specific models revealed an important pattern. Relative differences in parity were greatest among younger women, meaning the association between child loss and additional births was particularly pronounced earlier in the reproductive life course. Absolute differences, however, increased with age, reflecting the additional time available for women to have further pregnancies. The distinction is technically significant: relative measures emphasize how many times larger one rate is than another, whereas absolute margins describe the estimated number of additional children. Together, the results suggest that loss can be associated with both an elevated intensity of childbearing and a longer period during which births may occur.

The complete birth histories offered a more direct view of what happened after a loss. Among women who had experienced at least one under-five death, 85.5% subsequently had another birth. This finding does not mean that every child death was followed by another pregnancy, nor does it establish that additional births were replacements in a purely mechanical sense. People’s reproductive decisions can reflect economic conditions, family expectations, social norms, maternal health, partner preferences, access to contraception and the timing of bereavement. Still, the high proportion of subsequent births is consistent with the broader parity analysis and shows that child loss remained closely connected to continued childbearing.

The findings also reveal that progress in child survival has not erased the relationship between mortality and fertility. Although relative differences were smaller in more recent survey periods, the association persisted across age groups and historical periods. This matters because Malawi has experienced substantial reductions in under-five mortality, creating a different demographic environment from the high-mortality settings in which replacement fertility was most often discussed. Even so, the new results indicate that the demographic imprint of a child’s death has not vanished with improved survival rates.

Several mechanisms could plausibly link child loss to later births. One possibility is “replacement,” in which parents have another child after a loss. Another is insurance: additional children may be intended to protect a family against future bereavement, although children are not interchangeable with the specific child who died. Social networks, community responses to grief, the roles expected of mothers and fathers, and the perceived security of larger families may also influence the decision. The survey data identify these patterns at the population level, but they do not directly establish which explanation dominates or whether every additional birth was intended as a replacement.

From a public-health perspective, the results argue against treating child death as a discrete event that ends once a bereaved family leaves the clinic or community. Reproductive-health services need to remain available during and after loss, with nonjudgmental support for women and couples deciding whether and when to have another child. Counseling, access to contraception, maternal mental-health care, social support and follow-up after a child’s death are all relevant components. The aim is not to tell families how many children they should have, but to ensure that reproductive decisions after loss are informed, voluntary and supported.

The study used publicly available, fully de-identified survey data, and its statistical approach accounts for survey sampling weights while allowing the researchers to compare age groups, loss categories and survey periods. Its findings do not prove that child loss causes higher parity; women facing different health risks, poverty levels or family circumstances may differ in both child survival and fertility. But the size and persistence of the observed associations, together with the birth-history result, provide compelling evidence that under-five death remains an important factor shaping reproductive lives in Malawi. As survival improves, the demographic “ghost” of child loss may become less common, yet it has not vanished from the country’s birth histories.

Subject of Research: Association between under-five child loss and women’s parity in Malawi from 1992 to 2024

Article Title: The ghost of mortality: child loss and parity in Malawi, 1992–2024

Article References: Kachola, S. D., Mwandama, R., Chipala, G. A., & Chirwa, G. C. (2026). The ghost of mortality: child loss and parity in Malawi, 1992–2024. BMC Public Health. https://doi.org/10.1186/s12889-026-29732-9

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29732-9

Keywords: Malawi, child loss, under-five mortality, fertility, parity, replacement fertility, demography, Demographic and Health Surveys, family planning, maternal health, ghost, mortality

The most striking reversal concerns the desire for partnership itself. The share of respondents who said they do not want a relationship climbed steadily to a peak of 32 percent in 2021, but has since fallen to 24 percent in 2026. Over a longer arc, the change is even more pronounced: in 2010, 33 percent of singles said they would like to marry someday; by 2026 that figure had risen to 45 percent. Yet the institution of marriage is being reimagined rather than simply embraced. The ideal age for marrying has increased, as has the ideal length of dating before a wedding, and roughly 30 percent of respondents said they would be open to a long-term committed relationship with no intention of marrying at all. The data point to a population that still wants deep attachment but is increasingly flexible about the legal and social packaging that comes with it.

Attitudes toward attraction are shifting in two directions at once, a tension the researchers themselves flagged. Belief in love at first sight jumped dramatically from 41 percent in 2010 to 62 percent in 2026, and the share of singles who say they have actually experienced it rose from 30 percent to 47 percent. At the same time, the slow burn is thriving: nearly half of singles, 49 percent, report having fallen for someone they did not initially find attractive, up from 30 percent in 2010. The most commonly cited catalysts were great conversations, shared interests and becoming best friends, though self-improvement factors such as greater emotional maturity, improved finances and clearer life goals gained in importance over the same period. Singles are also more willing to give a lukewarm first date a second chance, with 41 percent saying so in 2026 compared with 35 percent in 2021.

That openness coexists with sharpened selectivity. The proportion of singles maintaining a checklist for a long-term partner rose from 25 percent in 2021 to 34 percent in 2026, and fewer reported falling in love with someone who failed to meet most of their criteria. Younger singles are vetting prospects with unprecedented rigor: half of Gen Z respondents said they screen or research dates online before meeting in person, most often through social media, cited by 60 percent, but also through Google searches, used by 37 percent, and background checks, used by 29 percent. Dr. Justin Garcia, Executive Director of the Kinsey Institute and co-lead of the study, observed that there is an interesting tension in the data: singles today hold clear expectations for a partner, yet love still has the ability to surprise them, since nearly half have fallen for someone they were not initially attracted to and conversation, shared interests and values can change how they see a person.

Economic anxiety looms over nearly every relationship decision the survey measured. More than half of singles, 52 percent, said the difficult economy made them more interested in finding someone to share their life with, nearly double the 27 percent who said the same in 2013. Yet insecurity cuts both ways: compared with 2019, more singles reported needing to reach a certain career and income level, build cash reserves, pay off debt or own a home before pursuing a long-term relationship. When asked to name their top three day-to-day stressors, the most selected answer was concern about the economy or finances, chosen by 54 percent of respondents, and when asked what would make their lives happier, the most common answer, selected by 56 percent, was simply more money. Financial readiness has become a gatekeeper to romance for a substantial share of the single population.

The economic mood is also reshaping family plans. Just 38 percent of singles aged 18 to 49 said they want children in the future, with a notable gender gap: 42 percent of men versus 32 percent of women. Half of all respondents named financial stability as a top factor in deciding whether to become a parent, and more than a third said their financial situation, cited by 40 percent, or the state of the world, cited by 34 percent, had pushed their timeline for children later. Attitudes toward caregiving roles showed a complicated trajectory. In 2013, 34 percent of respondents overall believed women should be the primary caregiver for children; by 2026 that figure had risen to 51 percent, and among Gen Z men it reached 70 percent, even though 72 percent of those same men said it was acceptable in their own relationship to be a stay-at-home parent. For Gen Z, social media was the most commonly reported influence on attitudes about gender roles in romantic relationships, outranking friends, family and past relationship experiences.

Perhaps the sharpest declines in the dataset concern alternative paths to parenthood. Willingness to consider fertility treatments such as in vitro fertilization collapsed from 44 percent in 2017 to 18 percent in 2026, and openness to egg freezing fell from 33 percent to 17 percent over the same period. Willingness to consider adoption dropped from 53 percent to 27 percent. The magnitude of these shifts suggests that the rising costs and complexity of building a family, combined with shifting cultural attitudes, are narrowing the range of options singles can realistically imagine for themselves, a trend with potential implications for future fertility and adoption patterns across the country.

On questions of difference and compatibility, the picture is nuanced. Despite their longer checklists, singles, and especially men, report growing flexibility about dating people with very different views on religion, social issues and finances. Since 2019, willingness to fall in love with someone of a different religious faith rose from 43 percent to 57 percent, on social issues from 44 percent to 56 percent, and on approaches to money from 49 percent to 56 percent. Political differences, by contrast, changed little overall in terms of willingness to date across the aisle, yet political labels themselves have become more likely to be outright dealbreakers, particularly among Gen Z. Compared with 2015, more singles now say that being a Republican, Democrat or Independent would rule out a potential partner, and those exclusions have grown substantially stronger within roughly the past year.

What singles want in a partner, meanwhile, sounds less like a fantasy and more like a foundation. When considering someone for a committed relationship, the most selected trait, chosen by 39 percent of respondents as part of their top three, was someone they can trust and confide in, followed by emotional maturity at 28 percent. The hallmarks of a healthy relationship were defined as mutual respect, cited by 53 percent, open communication at 52 percent, and a feeling of safety and security at 40 percent. Older singles aged 39 and above reported valuing honesty, reliability and emotional connection more as they have aged, and roughly half of all Gen Z and Millennial respondents want a partner who has been to therapy. Dr. Amanda Gesselman, a Senior Research Scientist at the Kinsey Institute and study co-lead, said the data show singles becoming more flexible over time about what a good relationship can look like, with traditional milestones becoming less essential as people place more value on the kind of person they want their partner to be; across ages, genders and sexual orientations, she noted, nearly everyone is looking for a long-term partner they can trust, laugh with and experience strong sexual chemistry with.

Even the etiquette of rejection and the tools of courtship are being transformed. Only 35 percent of singles said they would tell someone face-to-face that they were not interested in seeing them again, and just 37 percent would say so by text. Instead, subtle signals have proliferated: offering to split the check, ending a date with a polite it was nice to meet you, or offering a handshake or hug instead of a kiss have become increasingly common ways to communicate disinterest, while ghosting and slow fading have held steady. Ironically, 60 percent of respondents said they would prefer some form of direct face-to-face communication when they are the ones being turned down. Technology is also embedding itself in romance through artificial intelligence: nearly 4 in 10 singles, 39 percent, have already used AI in their dating lives, most often to improve communication, find better matches or generate message ideas. Usage is heavily generational, with 67 percent of Gen Z singles reporting AI use compared with 46 percent of Millennials, 24 percent of Gen X and just 5 percent of Boomers, and men more likely than women to have tried it, at 47 percent versus 30 percent. Yet skepticism remains strong: 34 percent consider using AI to alter dating profile photos a dealbreaker, 30 percent object to a partner relying on AI for all their conversations, and while 30 percent believe AI could improve human connection, 66 percent insist it could never replace it. Taken together, the fifteen-year record portrays a generation of American singles who are more deliberate, more financially cautious and more technologically assisted than ever, yet still fundamentally searching for the same thing: a trustworthy partner and a durable bond.

Subject of Research: Longitudinal survey research on the dating attitudes, relationship goals, family planning and technology use of single adults in the United States

Article Title: 15th annual Singles in America Survey reveals how relationships, marriage, money and family are changing

Article References: 15th annual Singles in America Survey reveals how relationships, marriage, money and family are changing. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: Singles in America, Kinsey Institute, dating, marriage, relationships, economic insecurity, fertility, Gen Z, artificial intelligence, gender roles, survey research, social trends

The core clinical problem is a delicate biochemical balancing act. In 21-hydroxylase deficiency, impaired cortisol synthesis causes the adrenal glands to accumulate precursor steroids, including 17-hydroxyprogesterone and androstenedione, which are shunted into androgen production. Some of these precursors are converted into potent androgens such as dihydrotestosterone, including via the so-called backdoor pathway, driving virilisation. Treatment therefore aims to suppress excess adrenal androgens with glucocorticoids, but overtreatment carries its own toll: obesity, insulin resistance, hypertension and reduced bone mineral density. Undertreatment, by contrast, risks accelerated skeletal maturation, compromised adult height and progressive virilisation. During puberty, this tightrope becomes harder to walk because rising sex hormones, growth hormone and IGF-1 alter cortisol metabolism and clearance, and renal cortisol clearance itself increases, producing higher and more variable hydrocortisone requirements.

Diagnosis is its own puzzle during adolescence. Activation of the hypothalamic-pituitary-gonadal axis, together with adrenarche, floods the circulation with adrenal and gonadal androgens such as DHEA, DHEA sulphate, androstenedione and testosterone, which can mimic CAH both clinically and biochemically. This is particularly relevant for non-classic CAH, the milder form in which roughly 20 to 50 percent of enzyme activity is preserved. Unlike salt-wasting CAH, which presents in infancy with less than one percent residual activity, or simple virilising CAH, which emerges in childhood, non-classic CAH often first announces itself in adolescence with acne, hirsutism, accelerated growth or menstrual irregularity, all features that are common in healthy teenagers and therefore poorly specific. Prevalence estimates range from one in 200 to one in 1,000, with higher rates in some groups such as Ashkenazi Jews, and many affected individuals, especially males, remain asymptomatic because gonadal androgen production dwarfs the adrenal contribution.

The biochemical picture of untreated non-classic CAH adds further nuance. Basal cortisol and aldosterone are typically normal, with only mildly elevated androgens and 17-hydroxyprogesterone, and sub-optimal cortisol responses to ACTH stimulation testing appear in up to 60 percent of untreated patients. Yet symptomatic cortisol deficiency is strikingly rare: more than 90 percent show no signs of hypocortisolism, and in larger series potential features of adrenal insufficiency were observed in only about one percent. The review notes that this apparent protection may reflect intermediary cortisol metabolites binding the glucocorticoid receptor, elevated free cortisol levels, or receptor polymorphisms that heighten cortisol sensitivity. Distinguishing non-classic CAH from polycystic ovary syndrome, idiopathic hirsutism, differences of sex development and, in cases of rapid-onset hyperandrogenism, adrenal or gonadal tumours requires a layered workup spanning androgens, gonadotrophins, imaging, dexamethasone suppression testing and genetic studies, and the authors caution that mild borderline biochemistry risks overdiagnosis.

For adolescents with classic CAH, therapy revolves around hydrocortisone at 10 to 15 milligrams per square metre per day, supplemented with fludrocortisone where mineralocorticoid replacement is needed. Hydrocortisone is preferred because longer-acting glucocorticoids such as prednisolone and dexamethasone suppress growth more strongly. Monitoring blends clinical assessment of growth, bone age, pubertal stage and features of hyperandrogenism with biochemical markers including morning pre-dose 17-hydroxyprogesterone, androstenedione and testosterone, while blood pressure, sodium, potassium and renin track fludrocortisone adequacy. Because responses vary widely, the authors stress the need for clinical and biochemical review every three to six months. Puberty compounds the difficulty: falling insulin sensitivity, which is already increased in CAH compared with BMI-matched controls, drives hyperinsulinaemia that suppresses sex hormone binding globulin, raising free testosterone and, in girls, potentially stimulating ovarian testosterone production.

Non-classic CAH demands a different calculus. Many patients need no treatment at all, and daily hydrocortisone is generally not recommended either to correct mild biochemical cortisol deficiency or as first-line therapy for hyperandrogenism or menstrual irregularity, since the cardiovascular, metabolic and bone risks of daily glucocorticoids can outweigh the benefits. Where treatment is sought, alternatives exist: cosmetic measures, topical eflornithine, spironolactone and flutamide for hirsutism; benzoyl peroxide, antibiotics and retinoids for acne; and anti-androgenic contraceptives for menstrual disturbance. Hydrocortisone started in childhood to protect final height can often be discontinued once adult height is achieved, with stress dosing reserved for those with sub-optimal ACTH responses.

Novel therapies are reshaping the landscape. Modified-release hydrocortisone formulations, which more closely imitate physiological cortisol secretion, may reduce daily dose requirements, restore menstrual cycles, improve fertility prospects and lower the likelihood of adrenal crises. Crinecerfont, an oral corticotropin-releasing factor type 1 receptor antagonist, has shown in phase 3 paediatric trials the potential to bring glucocorticoid dosing down from supraphysiological to physiological levels by dampening the drive to the adrenal axis. Long-term outcome data in adolescents started on either approach remain limited, however, and adherence remains the Achilles heel of every regimen. Autonomy, psychosocial pressure and treatment fatigue frequently produce inconsistent medication use, risking hyperandrogenism, menstrual irregularity and life-threatening adrenal crises. Structured education, simplified dosing, digital reminders, motivational interviewing and shared decision-making all help, as does practical advice such as taking the morning dose on time before going back to sleep. Every adolescent should carry an emergency hydrocortisone kit and be trained, alongside caregivers and school staff, in sick day rules and early symptom recognition.

Surgical and reproductive issues add a deeply personal dimension. Many adolescent girls with CAH have undergone feminising genitoplasty in infancy, and the review emphasises that clinicians must understand which procedures were performed, since complications can include fistulae, vaginal stenosis, reduced clitoral sensitivity, poor aesthetic outcomes and adverse psychosexual consequences. Whether to operate, and when, remains controversial, with no consensus among researchers, clinicians or patients, and some experts now advocate delaying surgery until adolescence when the individual can give informed consent. An examination under anaesthetic in early adolescence, before menarche, can inform discussions about future sexual function and possible obstruction to menstrual flow. Fertility deserves early conversation too: in males, testicular adrenal rest tumours, thought to arise from embryonic cells and driven by chronic ACTH stimulation, can impair spermatogenesis, making regular testicular ultrasound screening from before puberty and optimised glucocorticoid therapy important protective measures, while in females hyperandrogenism and prior genital surgery may affect ovulation and sexual wellbeing.

Finally, the psychosocial toll is substantial and increasingly well documented. Health-related quality of life is often broadly preserved, but studies report impairments in emotional, social and school functioning, with treatment burden, body image concerns, fertility anxiety, disclosure difficulties and stigma all contributing, and non-classic disease generally carrying a lighter load than classic CAH. Most individuals assigned female at birth identify as female, though gender-atypical behaviour is more common and a small but increased prevalence of gender dysphoria has been reported, while the effect on sexual orientation remains unresolved. Population-based studies show elevated rates of anxiety, depression and hospital-treated psychiatric conditions compared with matched controls, with poorly controlled disease associated with worse psychological outcomes. Transition to adult services emerges as a decisive intervention point: poorly structured handover leads to loss to follow-up and deteriorating health, whereas early preparation from around age 12 to 14, staged education, joint paediatric-adult clinics and structured frameworks such as Ready, Steady, Go can sustain engagement. The authors conclude that only multidisciplinary, patient-centred care, integrating endocrine expertise with psychological and social support, can optimise both clinical outcomes and quality of life for this often overlooked group.

Subject of Research: Diagnostic, therapeutic and psychosocial challenges facing adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Article Title: Medical and social challenges awaiting adolescents with congenital adrenal hyperplasia

Article References: Nixon, M., & Davies, J. H. (2026). Medical and social challenges awaiting adolescents with congenital adrenal hyperplasia. Frontiers in Adolescent Medicine, 4, Article 1870467. https://doi.org/10.3389/fradm.2026.1870467

Image Credits: AI Generated

DOI: 10.3389/fradm.2026.1870467

Keywords: congenital adrenal hyperplasia, 21-hydroxylase deficiency, adolescence, puberty, glucocorticoids, hyperandrogenism, non-classic CAH, adrenal crisis, transition care, fertility, mental health, genitoplasty

Anti-mullerian hormone is produced by the granulosa cells of small growing follicles, and its serum level correlates with the number of follicles recruited into the growth phase at any given time. Because it remains relatively stable across the menstrual cycle, it can be measured on any day, although the study protocol here drew samples on days two through five to allow simultaneous measurement of follicle stimulating hormone and estradiol, which do fluctuate cyclically. Follicle stimulating hormone rises as the reserve declines, because the pituitary must work harder to recruit follicles when inhibin and estradiol feedback from the ovaries weakens, but by the time FSH becomes clearly elevated the reserve is often already substantially depleted, making it a relatively late and less sensitive marker. Antral follicular count, performed by transvaginal ultrasonography during the early follicular phase, counts the small follicles between roughly two and ten millimeters in diameter that are visible on both ovaries, and it generally correlates well with AMH because both reflect the same pool of growing follicles. Ovarian volume, the third ultrasonographic parameter used in a subset of patients, is a coarser measure that shrinks as the cortex is depleted of follicles, but it is less precise and more operator dependent.

The finding that nearly half of the studied cohort had AMH below one nanogram per milliliter, and that roughly two thirds fell below the tenth centile of age-matched healthy fertile women on nomogram comparison, is striking given the young mean age of twenty-seven years. Nomogram comparison is an important methodological choice here, because AMH declines with age in all women, and simply reporting mean values would obscure whether lupus patients are tracking below the curve expected for their age. By anchoring the comparison to population-specific centiles derived from healthy fertile women, the investigators could quantify how many patients were shifted toward the low end of the distribution beyond what age alone would explain. The use of Indian reference nomograms also matters, since preliminary evidence suggests that ovarian ageing may proceed somewhat faster in healthy Indian women than in populations from which many older reference ranges were derived, which would make the observed deficits even more notable if the lupus patients fell below even these local benchmarks.

The independent associations uncovered by the multivariable regression offer several threads for interpretation. The association with higher age is expected and mirrors the physiology of ovarian ageing, with each additional year carrying a modest but measurable increase in the odds of low AMH. The association with active disease is more intriguing, because it suggests that inflammatory activity itself, rather than merely the passage of time or the scars of past treatment, may be eroding the follicular pool. Several mechanisms could plausibly underlie such an effect. Systemic inflammation in lupus involves circulating cytokines such as interleukin-6 and tumor necrosis factor alpha, which can disrupt the hypothalamic-pituitary-ovarian axis and impair follicular development. Autoantibodies, immune complex deposition, and microvascular injury could compromise the blood supply to the ovary, and the ovary is notably vulnerable to ischemic damage because its follicular complement cannot regenerate. Oxidative stress generated by chronic inflammation may also accelerate apoptosis of oocytes and granulosa cells. The cross-sectional design of the study cannot distinguish whether active disease caused the low reserve or whether both reflect a shared underlying susceptibility, but the association is biologically coherent and aligns with observations in other inflammatory conditions where disease activity correlates with diminished reserve.

The link with menstrual irregularities, which more than quadrupled the odds of low AMH, is easier to interpret in one direction at least, since anovulation and oligomenorrhea frequently accompany a declining follicular pool. However, the relationship may also run partly in reverse, because lupus itself, thyroid dysfunction, hyperprolactinemia, stress, and weight changes can all disrupt cyclicity independently of reserve, meaning that menstrual irregularity is an imperfect proxy. Its strong statistical association with low AMH nonetheless suggests that clinicians seeing lupus patients with new cycle disturbances should consider ovarian reserve assessment rather than attributing the change solely to disease flares or medication effects.

The signal for anti-Ro60 positivity, which narrowly missed conventional statistical significance with a confidence interval crossing unity, is worth considering despite its borderline status. Anti-Ro antibodies are classically associated with neonatal lupus and congenital heart block, but they have also been implicated in adult autoimmune epithelial dysfunction, most notably in Sjogren syndrome and in the lymphocytic infiltration of salivary and lacrimal glands. Some investigators have proposed that similar lymphocytic infiltration of the ovary, sometimes described in the context of premature ovarian insufficiency, could be driven by the same antibody specificities, providing a plausible autoimmune route to follicular depletion that is independent of any gonadotoxic treatment. The modest effect size and borderline p value mean this finding requires confirmation in larger cohorts, but its biological plausibility and consistency with the broader concept of autoimmune premature ovarian failure make it a hypothesis worth pursuing.

Equally informative are the associations that failed to materialize. The absence of a relationship with prior cyclophosphamide exposure may seem surprising given the established gonadotoxicity of that agent, but several explanations are possible. The cumulative doses received by patients in this cohort may have been relatively low or administered with gonadoprotective measures, the most susceptible patients may have already been excluded through the low AMH screening threshold used in the parent trial, or the cross-sectional design may have selected for survivors whose reserve was already depleted regardless of treatment history. The lack of association with nephritis, anti-dsDNA, anti-Sm, and antiphospholipid antibodies suggests that organ damage patterns and specific autoantibody profiles other than anti-Ro are not the primary drivers of reserve loss, which redirects attention toward disease activity as the modifiable factor of interest.

The very low observed prevalence of premature ovarian insufficiency and early menopause, at under two percent each, coexists somewhat paradoxically with the high proportion of subnormal AMH values. This apparent tension resolves when one appreciates that premature ovarian insufficiency is a clinical diagnosis requiring amenorrhea and consistently elevated gonadotropins before the age of forty, representing the extreme tail of a distribution, whereas low AMH identifies women whose reserve is shifted downward long before they reach that threshold. Many women with low AMH will never develop premature menopause, and the interval between a low reserve measurement and actual menopause can span years to decades. The clinical implication is that low AMH in a young lupus patient should prompt counseling about reproductive timelines and consideration of fertility preservation options, but it should not be presented as a prediction of imminent sterility, which the evidence does not support and which can cause unnecessary distress.

For patients and clinicians, the practical takeaways are several. First, ovarian reserve assessment with AMH, and where available antral follicular count, is a reasonable component of comprehensive reproductive counseling for women with lupus, particularly those approaching their thirties, those with persistently active disease, and those with menstrual disturbances. Second, the finding that active disease independently predicts diminished reserve adds a reproductive dimension to the already compelling case for early and sustained disease control, since suppressing inflammation may protect not only organs but also the follicular pool. Third, the absence of an association with cyclophosphamide in this cohort should not be generalized to dismiss gonadotoxic risk, which is well established at higher cumulative doses, but it does suggest that reserve loss in lupus is not solely a treatment artifact. Fourth, women with low reserve who wish to delay childbearing should be informed about oocyte cryopreservation and other fertility preservation strategies, ideally before reserve declines further, and assisted reproductive technologies can be planned with realistic expectations when the time comes. Finally, the ethno-geographic dimension highlighted by this study underscores the need for population-specific reference ranges and for research across diverse cohorts, since findings from European and North American populations may not translate directly to South Asian patients, and the burden of lupus in India makes locally relevant evidence especially valuable for guiding care.

Subject of Research: Ovarian reserve in reproductive age Indian women with lupus

Article Title: Assessment of ovarian reserve in reproductive age Indian women with lupus and determination of correlates of diminished reserve: results from a tertiary care centre

Article References: Jain, S., Kumar, A., Verma, U. S., Gupta, S., Bharti, J., Gupta, R., Goswami, R. P., Bhadu, D., Soneja, M., Sinha, S., Kumar, U., & Wig, N. (2026). Assessment of ovarian reserve in reproductive age Indian women with lupus and determination of correlates of diminished reserve: results from a tertiary care centre. Frontiers in Lupus, 4, Article 1783078. https://doi.org/10.3389/flupu.2026.1783078

Image Credits: AI Generated

DOI: 10.3389/flupu.2026.1783078

Keywords: lupus, SLE, ovarian reserve, AMH, fertility, autoimmunity, Assessment, ovarian, reserve, reproductive, Indian, women

Fertility is an unusually difficult outcome to study in relation to weather. Unlike hospital admissions or electricity demand, births are observed only after a long and partly private sequence of biological events and personal decisions. A single hot day can influence how couples spend their time, whether conception occurs, whether an early pregnancy survives, how long gestation lasts, and when a delivery finally happens. Monthly birth counts therefore bundle together several margins that need not move in the same direction or at the same time. A dip in births nine months after a hot month might mean fewer conceptions, unrecorded early pregnancy losses, or simply shifts in delivery timing—and aggregate statistics alone cannot tell these stories apart.

The exposure measure creates a second, subtler problem, and it is here that the study makes its central contribution. Daily maximum temperature records only the hottest moment of the day, typically a brief afternoon peak. A short spike and a relentlessly hot day can land in the same statistical category, even though they impose very different burdens on the body. Daily minimum temperature tells a different story: a high minimum usually means the night offered little relief, disrupting sleep and physiological recovery. Daily mean temperature summarizes conditions across the whole day. Because these three metrics are correlated but not equivalent, an analysis that relies on just one of them may attribute to a fleeting peak a relationship that actually belongs to sustained heat.

To disentangle these possibilities, Fu assembled an unusually rich dataset. Monthly vital statistics for all 47 Japanese prefectures from January 2012 through December 2019—a balanced panel of 4,512 prefecture-months containing more than eight million live births—were linked to daily weather reconstructed directly from raw Japan Meteorological Agency station records. For each prefecture, the three stations nearest its geographic center were selected and combined using inverse-distance-squared weights, with strict quality screening to exclude unreliable observations. The outcome variable was the monthly general fertility rate: live births per 1,000 women aged 15 to 49, a denominator that clearly defines the population at risk.

The statistical design is deliberately demanding. Each regression includes a full vector of temperature bins, lagged precipitation, and counts of missing weather days, alongside three layers of fixed effects: year-month effects that absorb nationwide shocks, prefecture-by-calendar-month effects that let each prefecture follow its own seasonal rhythm, and prefecture-by-year effects that soak up slow-moving local conditions. This means the temperature coefficients are identified not from comparing hot prefectures with cool ones, but from within-prefecture departures from a location’s usual month-specific exposure. Standard errors were clustered by prefecture, with additional checks using two-way clustering, spatial-temporal inference, and Benjamini-Hochberg adjustments across the full dynamic path of 28 lead and lag estimates per metric.

The results draw a sharp line between exposure measures. Days with daily maximum temperatures of at least 30 degrees Celsius showed only a fragile association with fertility: the lag-nine estimate of roughly 0.23 percent lower fertility was borderline under standard clustering, not significant under two-way clustering, and essentially vanished once complete daily-mean temperature bins entered the model jointly. By contrast, a day with a minimum temperature of at least 25 degrees Celsius was associated with 0.39 percent lower fertility nine months later and 0.25 percent lower fertility ten months later, with the lag-nine estimate surviving both two-way clustering and false-discovery adjustment. A day with a mean temperature of at least 30 degrees Celsius was associated with about 0.50 percent lower fertility at lag ten, and the cumulative mean-temperature association remained negative even when maximum-temperature bins were controlled simultaneously.

The dynamic analysis reinforces this pattern. Plotting the full path from placebo leads through 24-month lags, the maximum-temperature series shows a negative point at lag nine but no concentration of precise negative estimates across the gestational window. The minimum-temperature path reaches its most negative and most precisely estimated value at lag nine, while the mean-temperature path is negative at both lags nine and ten. Future-temperature placebo leads, which test whether the design is merely picking up residual seasonality, were centered around zero and none survived adjustment. Under the within-metric false-discovery corrections, only the minimum-temperature lag-nine estimate cleared the strictest threshold.

What can these estimates actually mean? The study is careful on this point. A decline in births nine or ten months after hot weather is compatible with several mechanisms: couples conceiving less often, early pregnancies being lost before clinical recognition, or gestational lengths shifting. The recorded fetal-death check did not resolve the question, partly because Japan’s statistical definition begins at 12 completed weeks of gestation and combines spontaneous and induced fetal deaths, omitting the earliest losses entirely. Nor did the data identify a behavioral pathway; prior time-use evidence from Hungary found no significant effect of hot days on sexual activity, weighing against treating reduced intercourse as an established general mechanism. The estimates are reduced-form relationships between outdoor measures and monthly fertility, not laboratory parameters ranking the physiological potency of different temperature metrics.

The study also translates its estimates into concrete scale. Using the jointly estimated lag-nine and lag-ten coefficients, the model implies that observed mean-temperature exposure was associated with roughly 5,418 fewer births relative to the reference-bin counterfactual over 2013 to 2019. An illustrative scenario of one additional day per prefecture-year with mean temperature at or above 30 degrees implies about 533 fewer births per year. Crucially, these are gross short-run accounting differences around the gestational horizon, not forecasts of lifetime births. The analysis cannot follow individual households across time, and the absence of a clear rebound through 24 months does not prove that conceptions never occur later—compensation may happen beyond the observed window or through timing shifts that aggregate imperfectly.

The broader lesson extends well beyond Japan. Temperature metrics are not interchangeable labels for a single treatment: maximum temperature emphasizes the daytime peak, minimum temperature the overnight trough and recovery environment, and mean temperature the cumulative daily burden. If buildings, air conditioning, and behavior mediate exposure, the mapping from ambient conditions to personal heat load varies across people and hours, and studies that compare coefficients without reconstructing all metrics consistently risk conflating data construction with biology. For climate-resilient reproductive-health planning, the findings suggest that heat-health surveillance should not rely on daytime maxima alone, since warm nights and sustained heat may flag the exposures that matter most. What remains needed, the author notes, are individual conception and pregnancy histories, gestational timing, early-loss measurement, indoor exposure data, and direct measures of adaptation—tools that would finally allow researchers to say not just whether heat shapes fertility, but how.

Subject of Research: The relationship between ambient temperature measures and short-run fertility rates in Japan

Article Title: Too hot to give birth? Temperature shocks and general fertility rates in Japan

Article References: Fu, Q. (2026). Too hot to give birth? Temperature shocks and general fertility rates in Japan. Frontiers in Human Dynamics, 8, Article 1899647. https://doi.org/10.3389/fhumd.2026.1899647

Image Credits: AI Generated

DOI: 10.3389/fhumd.2026.1899647

Keywords: heat, fertility, Japan, birth rates, temperature, climate change, general fertility rate, nighttime temperature, conception, pregnancy loss, environmental demography, fixed effects

ClpX, or Caseinolytic Protease X, is a member of the AAA+ family of ATP-dependent proteases. It sits inside the mitochondrial matrix, where it serves as the unfoldase component of the ClpXP proteolytic complex. In practical terms, ClpX grabs misfolded or damaged proteins, threads them through the pore of its partner protease ClpP, and ensures they are degraded before they can clump together and poison the organelle. This housekeeping function — mitochondrial proteostasis — is essential for any cell that depends heavily on its mitochondria, and the oocyte is arguably the most mitochondria-dependent cell in the body. Each mature egg carries tens of thousands of copies of mitochondrial DNA, and its energy metabolism must support not only its own maturation but also the earliest, most vulnerable stages of embryonic development.

The research team, led by Renwu Hua, Zhuo Hai and Tianren Wang of The University of Hong Kong-Shenzhen Hospital, together with colleagues in Wuhan, Shenzhen, Chicago and elsewhere, set out to ask what happens when this proteostasis machinery fails specifically in oocytes. Using a combination of genetic ablation and naturally aged mouse models, they showed that ClpX deficiency — whether engineered or age-related — disrupts mitochondrial proteostasis within the oocyte. The consequences are not subtle. Oocyte-specific knockout of the Clpx gene impaired oocyte quality and developmental competence, ultimately leading to female subfertility in the animals.

To understand what was going wrong at the molecular level, the investigators turned to two complementary technologies. Transcriptomic profiling of the oocytes revealed broad alterations in genes governing mitochondrial function, while nano-proteomic analysis — a technique sensitive enough to profile the protein composition of individual oocytes — demonstrated disrupted protein processing within the organelles. Together, these data painted a picture of an oocyte whose mitochondrial protein quality control had collapsed, leaving the cell unable to maintain the metabolic and structural integrity required for normal development.

But the most striking finding of the study was not simply that ClpX loss damages mitochondria. It was that the damaged oocytes activate a specific, druggable pathway. The team found that Clpx deficiency promoted the synthesis of prostaglandin D2, or PGD2, by upregulating the enzyme Ptgds, which catalyzes PGD2 production. PGD2 is a lipid signaling molecule best known for its roles in inflammation and sleep regulation, but its accumulation in the oocyte appears to be part of the damage response triggered by failing proteostasis — and, critically, part of the problem rather than the solution.

When the researchers treated Clpx knockout oocytes with AT-56, a pharmacological inhibitor of PGD2 synthesis, something remarkable happened: the developmental competence of the oocytes was restored. The same was true for oocytes from naturally aged mice, whose ClpX levels decline with age. In other words, blocking this single downstream signal could partially rescue the reproductive potential of oocytes that had already sustained mitochondrial proteostasis damage. The finding suggests that PGD2 is not merely a bystander in ovarian aging but an active mediator of oocyte decline — and one that can be pharmacologically intercepted.

The translational implications are what make this study genuinely exciting. The team did not stop at mouse models. In a proof-of-concept experiment, AT-56 administration improved the in vitro maturation of human oocytes. In vitro maturation, or IVM, is a fertility technique in which immature oocytes are retrieved from the ovary and matured in the laboratory before fertilization. It is used in patients undergoing fertility preservation, in polycystic ovary syndrome, and in cases where ovarian stimulation carries medical risks. But IVM success rates remain lower than those of conventional IVF, largely because immature oocytes retrieved from older or compromised ovaries often fail to mature properly or produce embryos with poor developmental potential. If a small molecule can improve the quality of these oocytes in the dish, the implications for assisted reproduction are substantial.

It is worth pausing on what this means for the broader field of reproductive aging. Ovarian aging is not just a fertility problem. It is associated with increased rates of infertility and miscarriage, adverse outcomes at menopause, and a range of age-related health conditions in women. Yet most research into ovarian aging has focused on the depletion of the ovarian follicle reserve — the shrinking pool of eggs — rather than on the quality of the eggs that remain. This study shifts the spotlight to a different question: what makes an aging oocyte competent or incompetent? The answer, at least in part, appears to lie in the oocyte’s ability to maintain its mitochondrial proteome, and in the signaling pathways that respond when that ability fails.

The work also highlights the importance of proteostasis — the maintenance of a healthy protein environment — as a theme in aging biology more broadly. Proteostasis decline is now recognized as a hallmark of aging in many tissues, from neurons to muscle, and the oocyte is no exception. What makes this study distinctive is that it identifies a specific mitochondrial unfoldase as the critical node, and then traces a complete causal chain from proteostasis failure, through a defined lipid signal, to a measurable reproductive outcome — and back again, via a drug that reverses the phenotype. That kind of mechanistic completeness is rare in reproductive biology, where many observations remain correlational.

There are, of course, important caveats. The human IVM experiment was a proof of concept, not a clinical trial, and AT-56 is a research compound rather than an approved medication. Whether PGD2 inhibition will prove safe and effective in human fertility treatment remains to be established through properly controlled studies. The mouse models, while informative, cannot fully capture the complexity of human ovarian aging, which unfolds over decades rather than months. And ClpX is only one node in what is likely a network of proteostasis factors whose relative contributions to oocyte decline remain to be mapped. Still, the study provides something the field has lacked: a concrete, mechanistically defined, pharmacologically tractable target for improving oocyte quality in the context of reproductive aging. For millions of women facing age-related fertility decline, and for the clinicians who help them, that is a finding worth watching closely.

Subject of Research: Mitochondrial unfoldase ClpX regulates oocyte competence during ovarian aging

Article Title: Mitochondrial unfoldase ClpX regulates oocyte competence during ovarian aging

Article References: Hua, R., Hai, Z., Zheng, T., Gu, J., Du, H., Guo, C., Su, J., Zhou, X., Yang, J., Wei, Y., Yin, T., Zhang, J. V., Liu, K., Yeung, W. S. B., Babayev, E., & Wang, T. (2026). Mitochondrial unfoldase ClpX regulates oocyte competence during ovarian aging. Cell Death Discovery. https://doi.org/10.1038/s41420-026-03335-0

Image Credits: AI Generated

DOI: 10.1038/s41420-026-03335-0

Keywords: ovarian aging, mitochondria, ClpX, oocyte quality, PGD2, fertility, in vitro maturation, proteostasis, infertility, reproductive biology, Mitochondrial, unfoldase

CAH is a group of autosomal recessive disorders caused by defects in the enzymes that manufacture cortisol in the adrenal glands. In roughly 90 percent of cases, the culprit is a mutation in the gene encoding 21-hydroxylase. When cortisol production falls short, the pituitary gland responds by pumping out adrenocorticotropic hormone, or ACTH, which chronically stimulates the adrenals and drives them to overproduce androgens. The severity of the resulting disease depends on how much residual enzyme activity remains. The classic salt-wasting form typically announces itself in the newborn period, the simple virilizing form preserves partial cortisol production, and the milder non-classic form often goes undetected until adolescence or adulthood, sometimes only surfacing during an infertility work-up. Diagnosis hinges on measuring 17-hydroxyprogesterone, the steroid precursor that accumulates when 21-hydroxylase is deficient, with newborn screening now enabling early detection of classic disease.

For girls and women with classic CAH, the endocrine obstacles to reproduction are formidable. Adrenal androgen excess disrupts follicular maturation and ovulation, while elevated 17-hydroxyprogesterone acts much like a contraceptive progestin: it binds the progesterone receptor or is converted to progesterone itself, thickening cervical mucus, impairing endometrial development and suppressing ovulation. Elevated androgens and progesterone can also disturb the pulsatile secretion of luteinizing hormone, further scrambling menstrual cycles. The clinical data are sobering. In a Swedish population-based cohort of 272 women with CAH, only 25.4 percent had at least one child, and affected women had fewer children and were older at the birth of their first child than controls. Menstrual disturbances occur in more than 30 percent of women with classic CAH who are not using hormonal contraception, and more severe genotypes are consistently associated with poorer reproductive outcomes.

Yet the picture is far from hopeless, and the review emphasizes that biology is only part of the story. Adequate glucocorticoid replacement can restore hormonal balance, and in well-controlled patients fecundity can approach that of the general population. In a multicenter study of 72 adult women with different CAH phenotypes, time to pregnancy was often prolonged, with a median ranging from 8 to 24 months, and about a quarter of the women required fertility-enhancing medication or assisted reproductive techniques. Despite that, live birth numbers per woman and miscarriage rates were broadly comparable to the general population. Intriguingly, lower birth rates in women with classic CAH may partly reflect a reduced desire for parenthood rather than absolute infertility: only 23.6 percent of women with classic disease in one study expressed a wish for pregnancy, compared with nearly half of women with non-classic CAH, a gap that points squarely at psychosocial influences.

Those psychosocial influences run deep. Psychosexual development in girls with classic CAH is shaped by prenatal androgen exposure, chronic endocrine imbalance, genital reconstructive surgery and body image concerns, factors that accumulate from early childhood onward. Females with CAH report higher rates of sexual dysfunction than controls, including vaginal stenosis, reduced lubrication, diminished genital sensitivity and painful intercourse, and in one cohort more than one-third of women with CAH had never engaged in vaginal intercourse at all. Repeated surgical procedures in childhood and adolescence carry significant psychological burden, and women with null mutations report lower sexual satisfaction and more surgical complications. Gender identity presents additional complexity: reviews suggest roughly 94.8 percent of 46,XX individuals raised as girls maintain a female gender identity, with about 4 to 5 percent experiencing gender identity difficulties, rates that rise substantially in those raised as males. Factors associated with later gender dysphoria include marked virilization, delayed diagnosis and poor hormonal control, underscoring the need for repeated, developmentally appropriate psychological assessment.

Non-classic CAH tells a subtler story in girls. Because the enzyme defect is milder, most affected girls have normal external genitalia and become symptomatic only in late childhood or adolescence, when hyperandrogenic features emerge. Premature pubarche is often the first sign, with one study finding that 92 percent of girls under ten presented this way. During adolescence, hirsutism, acne, alopecia and menstrual disturbances become prominent: in a cohort of 220 adolescents, 56 percent had irregular menses and 9 percent had primary amenorrhea. The phenotype closely resembles polycystic ovary syndrome, including polycystic ovarian morphology. Fertility is generally less affected than in classic disease and most women conceive spontaneously, but reduced fertility is still reported in 10 to 30 percent of women of reproductive age, primarily through anovulation. The stakes of early diagnosis are vivid: live birth rates were 86 percent in women diagnosed before conception versus 69 percent in those diagnosed only after pregnancy, and miscarriage rates fell from about 25 percent before diagnosis to roughly 10 percent after treatment began.

For males with classic CAH, the reproductive threats are different but equally serious. Hypogonadotropic hypogonadism, in which adrenal-derived steroids suppress the hypothalamic-pituitary-gonadal axis through negative feedback, is observed in 20 to 52 percent of men with 21-hydroxylase deficiency, and impaired semen quality or reduced sperm concentrations have been described in up to two-thirds of affected individuals. Multiple steroids contribute to this suppression, including testosterone acting through the androgen receptor, androstenedione after aromatization to estradiol, and 17-hydroxyprogesterone and progesterone through the progesterone receptor. Recently, 11-oxygenated adrenal androgens such as 11-ketotestosterone have emerged as potent contributors whose androgenic activity rivals that of classical androgens, potentially explaining why some men with low circulating testosterone show few obvious symptoms of deficiency. Because adrenal and testicular testosterone are biologically indistinguishable, clinicians can use the androstenedione-to-testosterone ratio, with values of 0.5 or higher suggesting significant adrenal contribution, to identify the source of hormonal disruption.

The most distinctive threat to male fertility, however, is the testicular adrenal rest tumor, or TART, a benign lesion that histologically resembles adrenocortical tissue and typically originates in the rete testis. Prevalence is estimated at 30 to 50 percent in adolescent boys and adult men with classic CAH, with bilateral occurrence in about 80 percent of cases. Tumors smaller than two centimeters cannot be detected by palpation, making scrotal ultrasound the diagnostic modality of choice, while magnetic resonance imaging offers no meaningful advantage. Current evidence suggests TARTs may arise not from embryonic adrenal rests, as long assumed, but from pluripotent steroidogenic cells, possibly fetal Leydig cell precursors, whose proliferation is driven by chronic ACTH excess and, during puberty, possibly by luteinizing hormone. Larger tumors can mechanically obstruct seminiferous tubules, damage Sertoli cells and germ cells, and produce azoospermia, and because they retain adrenal-like enzymatic machinery they can locally manufacture androgens, including 11-oxygenated varieties, that may further impair spermatogenesis through paracrine effects. Encouragingly, biochemical hypogonadism appears to be a stronger determinant of impaired spermatogenesis than tumor bulk alone, and intensifying glucocorticoid therapy to suppress ACTH can shrink tumors and sometimes restore fertility, an approach that works best in younger patients before fibrosis sets in.

The review’s practical recommendations follow from these findings. Boys with classic CAH should begin annual scrotal ultrasound screening for TARTs around age eight, and sperm cryopreservation should be offered when tumors are detected even if paternity is not yet desired. Preliminary evidence suggests a modified-release hydrocortisone formulation can improve sperm quality and gonadal function without increasing overall glucocorticoid exposure, while testis-sparing surgery has not been shown to improve fertility and should be reserved for pain. For women planning pregnancy, endocrine optimization is the cornerstone: hydrocortisone is preferred for its short half-life, adequate mineralocorticoid replacement may improve fertility even without overt salt wasting, and dexamethasone should be avoided during pregnancy because it crosses the placenta. Genetic counseling should be offered to all patients, beginning in adolescence, since classic 21OHD occurs in roughly 1 in 10,000 to 15,000 newborns and the carrier frequency is estimated at about 1 in 55 in the general population. Prenatal dexamethasone treatment, which must begin before gestational week eight to prevent virilization of affected female fetuses, remains controversial and is limited to specialized centers and research settings given unnecessary fetal exposure and uncertain long-term effects. Above all, the authors insist, structured transition care, beginning in early adolescence and tailored to readiness rather than age, with counseling on sexuality, fertility, contraception, inheritance and pregnancy planning delivered by multidisciplinary teams, is the single most powerful tool for converting these reproductive risks into manageable, and often reversible, challenges.

Subject of Research: Reproductive and fertility challenges in adolescents with congenital adrenal hyperplasia

Article Title: Reproductive and fertility challenges in adolescents with congenital adrenal hyperplasia

Article References: Tschaidse, L., Auer, M. K., Nowotny, H. F., & Reisch, N. (2026). Reproductive and fertility challenges in adolescents with congenital adrenal hyperplasia. Frontiers in Adolescent Medicine, 4, Article 1878713. https://doi.org/10.3389/fradm.2026.1878713

Image Credits: AI Generated

DOI: 10.3389/fradm.2026.1878713

Keywords: congenital adrenal hyperplasia, fertility, adolescence, 21-hydroxylase deficiency, testicular adrenal rest tumors, hyperandrogenism, psychosexual development, genetic counseling, transition care, endocrinology, pregnancy, reproductive medicine

Zygotic genome activation, commonly abbreviated ZGA, is the moment when a newly fertilized egg stops relying on the maternal RNA stockpiled inside the oocyte and begins transcribing its own genes at scale. In mice, this transition culminates during the 2-cell stage, with what researchers call major ZGA occurring in late 2-cell embryos. It is a famously fragile period. A large fraction of embryos cultured in vitro stall at exactly this point, failing to complete the switch from maternal to embryonic control. That developmental arrest is one of the central bottlenecks for assisted reproductive technologies, or ART, and any intervention that eases the passage through ZGA has direct clinical relevance.

The researchers began by comparing mouse embryos cultured under hypoxic conditions with those grown in normal atmospheric oxygen, and with embryos developing in vivo. The results were clear: hypoxic culture improved blastocyst formation and reduced developmental arrest during the ZGA window. When the team profiled gene expression in late 2-cell embryos, they found that the zygotic transcriptome of hypoxia-cultured embryos closely mimicked the patterns seen in physiologically developing, in vivo embryos during major ZGA. In other words, low oxygen did not merely push embryos along; it steered their gene expression toward a more natural trajectory, blunting the artificial signature that in vitro culture typically imprints on the embryonic genome.

To understand how oxygen levels could exert such an influence, the investigators turned their attention to histone modifications, the chemical tags that decorate the protein spools around which DNA is wound. Their focus fell on H3K4me3, the trimethylation of histone H3 at lysine 4, a mark long associated with active and poised promoters. Using CUT&Tag, a sensitive technique for mapping chromatin marks in scarce samples, the team compared H3K4me3 landscapes between hypoxia- and normoxia-cultured late 2-cell embryos. The comparison revealed a striking redistribution. Under hypoxia, H3K4me3 became specifically enriched at the promoters of zygotic genes, while it decreased at transposable elements and at oocyte-specific genomic domains.

That redistribution matters because it tracks precisely with what an embryo needs at this stage. Zygotic genes must be switched on, while the transcription of transposable elements and lingering oocyte programs must be restrained. The elevated H3K4me3 at zygotic promoters under hypoxia was not an isolated observation; the team showed that higher expression deciles of genes corresponded to progressively higher H3K4me3 levels, confirming the expected positive correlation between this mark and transcriptional output. Genes that were upregulated under hypoxia showed enhanced H3K4me3 around their transcription start sites, and genome browser views at representative loci such as Kank2 and Grb2 illustrated the pattern directly.

The mechanistic story deepened when the researchers examined how H3K4me3 related to chromatin accessibility and the machinery of transcription itself. Regions of the genome that were chromatin-accessible, regions enriched for RNA polymerase II, and regions enriched for the Ser2-phosphorylated form of RNA polymerase II, known as Ser2P, all exhibited higher H3K4me3 enrichment in hypoxia-cultured late 2-cell embryos. Ser2 phosphorylation is a critical modification of the polymerase’s C-terminal domain that marks the elongation phase of transcription, when RNA synthesis is actively proceeding along the gene body. The co-localization of the histone mark with these polymerase states suggested that H3K4me3 under hypoxia was not just a passive correlate of activity but was functionally entwined with both the initiation and the elongation of zygotic transcripts.

Direct measurements supported that interpretation. Global levels of RNA polymerase II and of its Ser2-phosphorylated form were both increased under hypoxia, and the polymerase was recruited to the very regions that had gained H3K4me3, initiating transcription and driving elongation there. Immunofluorescence imaging of 5-EU incorporation, which labels newly synthesized RNA, showed that transcriptional activity in hypoxia-cultured embryos matched that of in vivo embryos at the late 2-cell stage, reinforcing the physiological fidelity of the hypoxic culture condition. At key ZGA loci including Obox3, Klf17, Ep300 and L3mbtl2, the team observed the H3K4me3 and polymerase signals converging on the genes that define the embryonic program.

Perhaps the most compelling piece of evidence came from a pharmacological experiment. The researchers treated embryos with CPI-455, an inhibitor of the lysine demethylases that normally erase H3K4me3. Blocking demethylation raised H3K4me3 levels, and, crucially, Pol II and Ser2P signals increased as a result. That causality test ties the epigenetic mark to the transcriptional machinery in a directional way: when H3K4me3 is preserved, the polymerase arrives in greater numbers and proceeds more vigorously into elongation. It also implicates enzymes such as KDM5B, a lysine demethylase targeted by this class of inhibitors, as potential regulators of the ZGA landscape that hypoxia appears to counterbalance.

Not every consequence of hypoxia pointed toward activation. Consistent with the reduced H3K4me3 at repetitive elements, the team found lower LINE1 transcription in hypoxia-cultured embryos, while ERV1 and ERVK retrotransposon transcripts were significantly upregulated under normoxia in keeping with their elevated H3K4me3 marks; LINE2, ERVL, B2 and B4 elements showed no significant differences. This pattern suggests that hypoxia helps the embryo silence potentially destabilizing repeat transcription while sharpening the activation of genuine zygotic genes, a double benefit at a developmental stage when genome integrity and precise timing are both at a premium.

The broader significance of the study lies in the bridge it builds between clinical practice and basic developmental biology. Low-oxygen culture has been a mainstay of assisted reproduction largely on empirical grounds, adopted because embryos simply did better. With this work, the field gains a molecular rationale: hypoxia raises promoter H3K4me3, promotes chromatin accessibility, and orchestrates acute zygotic transcription by fueling both polymerase recruitment and productive elongation. The authors frame their findings as a theoretical foundation for optimizing ART protocols and improving clinical success rates. If the same H3K4me3-dependent mechanism operates in human embryos, it could inform how culture conditions are tuned, how embryo quality is assessed, and potentially how pharmacological agents that modulate histone methylation might be used to rescue embryos that would otherwise arrest. For now, the mouse data provide a vivid picture of an embryo’s first genetic awakening being tuned, quite literally, by the air it breathes, or rather by the carefully reduced oxygen that mimics the environment of the oviduct where early development naturally unfolds.

Subject of Research: Epigenetic regulation of zygotic genome activation under hypoxic embryo culture

Article Title: H3K4me3-dependent transcript elongation drives hypoxia-enhanced zygotic genome activation

Article References: Chen, B., Sun, X., Miao, Y., Sun, S., Deng, M., & Liu, H. (2026). H3K4me3-dependent transcript elongation drives hypoxia-enhanced zygotic genome activation. BMC Biology. https://doi.org/10.1186/s12915-026-02762-w

Image Credits: AI Generated

DOI: 10.1186/s12915-026-02762-w

Keywords: zygotic genome activation, hypoxia, H3K4me3, RNA polymerase II, transcript elongation, embryo culture, assisted reproductive technologies, chromatin, epigenetics, mouse embryo, BMC Biology, fertility